You can install PPMD to make it easier to access on your device. A network connection is still required to view medication and interaction information.
You should now see a icon on your home screen.
Tap then menu button, and then tap Install.
Not all web browsers and platforms support progressive web applications (PWA). Consult the documentation for your web browser for additional assistance.
N/A
The manufacturer preformed a pharmacokinetic (PK) study on the effect of co-administering darunavir/ritonavir (DRV/rtv) with telaprevir. They examined 600mg/100mg DRV/rtv twice daily for 20 days and 24 days. The 20 day dosing schedule was paired with telaprevir 750mg every 8 hours for 10 days (starting on day 11). The 24 day dosing schedule was evaluated with telaprevir 1125mg every 12 hours for 4 days and was just looking at the effect on darunavir.
Effect on telaprevir PK: The average telaprevir PK parameters were DECREASED by: Cmax=36%, AUC= 35%, Cmin=32%. 2.) Effect on darunavir PK when administered for 20 days with telaprevir 750mg every 8 hours for 10 days: The average darunavir PK parameters were DECREASED by: Cmax=40%, AUC=40%, Cmin=42%. 3.) Effect on darunavir PK when administered for 24 days with telaprevir 1125mg every 12 hours for 4 days: The average darunavir PK parameters were DECREASED by: Cmax=47%, AUC=51%, Cmin=58%. The manufacturer states it is NOT recommended to co-administer darunavir/ritonavir with telaprevir.
*The above interaction information is only for darunavir boosted with ritonavir, and not darunavir administered alone. There is no information available on the interaction of darunavir without ritonavir.
Van Heeswijk RP, Beumont M, Kauffman RS, Garg V. Review of drug interactions with telaprevir and antiretrovirals. Antiviral Therapy. 2013; 4: 553-560.